Annexon, Inc. (ANNX)
Nasdaq: ANNX · Pharmaceutical Preparations · Brisbane, CA · filing with the SEC since 2011
Who owns Annexon, Inc.
As filed with the SECHolders of 5% or more
6
Fmr LLC holds 11.9% of COMMON STOCK, as its SCHEDULE 13G/A filed Jul 8, 2026 says.
Directors and officers
13
report now, of 20 people on the record since 2020. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 6 named at left.
Holders of 5% or moreshare of the class, as filed
Fmr LLC
SCHEDULE 13G/A · filed Jul 8, 2026 · COMMON STOCK · 7.1% in Feb 5, 2026
Redmile Group, LLC
SCHEDULE 13G/A · filed Jul 8, 2026 · Common Stock, par value $0.001 per share · 9.9% in Feb 17, 2026
Blackrock, Inc.
SCHEDULE 13G/A · filed Jul 27, 2026 · Common Stock · 6.1% in Jan 21, 2026
Satter Muneer A
SCHEDULE 13D/A · filed Nov 21, 2025 · Common Stock, par value $0.001
State Street Corporation
SCHEDULE 13G · filed Aug 7, 2026 · COMMON STOCK
Bvf Partners L P/il
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock, par value $0.001 per share
BCLS I Investco, LP
SCHEDULE 13G/A · filed Feb 14, 2025 · Common Stock, par value $0.001 per share · reported falling below 5%
Point72 Asset Management, L.P.
SCHEDULE 13G/A · filed May 15, 2025 · Common Stock, par value $0.001 per share · reported falling below 5%
The Vanguard Group
SCHEDULE 13G/A · filed Mar 26, 2026 · Common Stock · reported falling below 5%, from 5.31% in Oct 30, 2025
Logos Global Management LP
SCHEDULE 13G/A · filed Aug 14, 2025 · Common Stock · reported falling below 5%, from 6% in Apr 28, 2025
What ANNX reports owning in othersstakes of 5% or more, and other ties
Annexon, Inc. reports no stake in another company in the record.
Insider tradesForm 4
10sales
14purchases
0sales on a scheduled plan
5people selling
$300,000sold, in dollars
$12.4Mbought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window9 of 40 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | 2 | $100,000 | 0 | 0 | $0 |
| Yednock Ted | EVP & CHIEF INNOVATION OFFICER | 2 | $100,000 | 0 | 0 | $0 |
| Artis Dean Richard | EVP & CHIEF SCIENTIFIC OFFICER | 2 | $100,000 | 0 | 0 | $0 |
| Dananberg Jamie | CHIEF MEDICAL OFFICER | 2 | $100,000 | 0 | 0 | $0 |
| Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | 2 | $100,000 | 0 | 0 | $0 |
| Carson William H. | director | 0 | $0 | 0 | 7 | $200,000 |
| Satter Muneer A | director | 0 | $0 | 0 | 6 | $12.0M |
| Love Douglas | PRESIDENT AND CEO | 0 | $0 | 0 | 1 | $100,000 |
| Choi Jung | director | 0 | $0 | 0 | 1 | $100,000 |